264 related articles for article (PubMed ID: 23678366)
1. Role of cellular iron and oxygen in the regulation of HIV-1 infection.
Nekhai S; Kumari N; Dhawan S
Future Virol; 2013 Mar; 8(3):301-311. PubMed ID: 23678366
[TBL] [Abstract][Full Text] [Related]
2. Protein Phosphatase-1 -targeted Small Molecules, Iron Chelators and Curcumin Analogs as HIV-1 Antivirals.
Lin X; Ammosova T; Kumari N; Nekhai S
Curr Pharm Des; 2017; 23(28):4122-4132. PubMed ID: 28677499
[TBL] [Abstract][Full Text] [Related]
3. Iron chelators of the di-2-pyridylketone thiosemicarbazone and 2-benzoylpyridine thiosemicarbazone series inhibit HIV-1 transcription: identification of novel cellular targets--iron, cyclin-dependent kinase (CDK) 2, and CDK9.
Debebe Z; Ammosova T; Breuer D; Lovejoy DB; Kalinowski DS; Kumar K; Jerebtsova M; Ray P; Kashanchi F; Gordeuk VR; Richardson DR; Nekhai S
Mol Pharmacol; 2011 Jan; 79(1):185-96. PubMed ID: 20956357
[TBL] [Abstract][Full Text] [Related]
4. Iron chelators ICL670 and 311 inhibit HIV-1 transcription.
Debebe Z; Ammosova T; Jerebtsova M; Kurantsin-Mills J; Niu X; Charles S; Richardson DR; Ray PE; Gordeuk VR; Nekhai S
Virology; 2007 Oct; 367(2):324-33. PubMed ID: 17631934
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HIV-1 transcription at 3% versus 21% oxygen concentration.
Charles S; Ammosova T; Cardenas J; Foster A; Rotimi J; Jerebtsova M; Ayodeji AA; Niu X; Ray PE; Gordeuk VR; Kashanchi F; Nekhai S
J Cell Physiol; 2009 Nov; 221(2):469-79. PubMed ID: 19626680
[TBL] [Abstract][Full Text] [Related]
6. CDK2 regulates HIV-1 transcription by phosphorylation of CDK9 on serine 90.
Breuer D; Kotelkin A; Ammosova T; Kumari N; Ivanov A; Ilatovskiy AV; Beullens M; Roane PR; Bollen M; Petukhov MG; Kashanchi F; Nekhai S
Retrovirology; 2012 Nov; 9():94. PubMed ID: 23140174
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
[TBL] [Abstract][Full Text] [Related]
8. Cyclin-dependent kinase 7 (CDK7)-mediated phosphorylation of the CDK9 activation loop promotes P-TEFb assembly with Tat and proviral HIV reactivation.
Mbonye U; Wang B; Gokulrangan G; Shi W; Yang S; Karn J
J Biol Chem; 2018 Jun; 293(26):10009-10025. PubMed ID: 29743242
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of cyclin T1/CDK9 complexes during T cell activation.
Garriga J; Peng J; Parreño M; Price DH; Henderson EE; Graña X
Oncogene; 1998 Dec; 17(24):3093-102. PubMed ID: 9872325
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinases as therapeutic targets for HIV-1 infection.
Rice AP
Expert Opin Ther Targets; 2016 Dec; 20(12):1453-1461. PubMed ID: 27797603
[TBL] [Abstract][Full Text] [Related]
11. C/EBPbeta regulates human immunodeficiency virus 1 gene expression through its association with cdk9.
Mameli G; Deshmane SL; Ghafouri M; Cui J; Simbiri K; Khalili K; Mukerjee R; Dolei A; Amini S; Sawaya BE
J Gen Virol; 2007 Feb; 88(Pt 2):631-640. PubMed ID: 17251582
[TBL] [Abstract][Full Text] [Related]
12. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
Rice AP
Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
[TBL] [Abstract][Full Text] [Related]
13. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
14. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
[TBL] [Abstract][Full Text] [Related]
15. Determining the Functions of HIV-1 Tat and a Second Magnesium Ion in the CDK9/Cyclin T1 Complex: A Molecular Dynamics Simulation Study.
Jin HX; Go ML; Yin P; Qiu XT; Zhu P; Yan XJ
PLoS One; 2015; 10(4):e0124673. PubMed ID: 25909811
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics.
de la Fuente C; Maddukuri A; Kehn K; Baylor SY; Deng L; Pumfery A; Kashanchi F
Curr HIV Res; 2003 Apr; 1(2):131-52. PubMed ID: 15043199
[TBL] [Abstract][Full Text] [Related]
17. Cyclin K inhibits HIV-1 gene expression and replication by interfering with cyclin-dependent kinase 9 (CDK9)-cyclin T1 interaction in Nef-dependent manner.
Khan SZ; Mitra D
J Biol Chem; 2011 Jul; 286(26):22943-54. PubMed ID: 21555514
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.
Ramakrishnan R; Liu H; Donahue H; Malovannaya A; Qin J; Rice AP
Retrovirology; 2012 Oct; 9():90. PubMed ID: 23110726
[TBL] [Abstract][Full Text] [Related]
19. Direct inhibition of CDK9 blocks HIV-1 replication without preventing T-cell activation in primary human peripheral blood lymphocytes.
Salerno D; Hasham MG; Marshall R; Garriga J; Tsygankov AY; Graña X
Gene; 2007 Dec; 405(1-2):65-78. PubMed ID: 17949927
[TBL] [Abstract][Full Text] [Related]
20. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome.
Sawaya BE; Khalili K; Gordon J; Taube R; Amini S
J Biol Chem; 2000 Nov; 275(45):35209-14. PubMed ID: 10931842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
